12.94
-2.19%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Chongqing Taiji Industry Group Co
Its shares trade on Shanghai under the ticker 600129.SS. It has been listed since 18 November 1997. In the fiscal year to 31 December 2025, it reported revenue of CN¥10.45bn and net income of CN¥120.6m. At that date it held total assets of CN¥14.42bn and shareholders' equity of CN¥3.50bn.
Chongqing Taiji Industry (Group) Co., Ltd. engages in the processing, production and distribution of Chinese patent medicines and health care products. The company is headquartered in Chongqing, Chongqing. The firm is also engaged in the cultivation of medicinal herbs. The firm's products mainly include capsules, syrup, oral liquid, lyophilized series, tablets, infusion series and injections. The firm mainly conducts its business in domestic and overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 18 Nov 1997
- Employees
- 12,704
- Website
- taiji.com ↗
Leadership
Pay as last reported
- Mr. Min YuChairman of the Board, since 2021
- Mr. Zunyi LiuChief Financial Officer
- Mr. Zongbin YuGeneral ManagerCN¥1.0m
- Ms. Qian JiangDeputy General Manager, Secretary of the Board, since 2015CN¥884,900
- Mr. Kang ChenDeputy General ManagerCN¥1.0m
- Ms. Haiyan CuiDeputy General ManagerCN¥884,900
- Mr. Liwen TanDeputy General ManagerCN¥884,900
- Mr. Yonghong YuanExecutive Deputy General Manager, since 2016CN¥2.7m
- Mr. Tong ChenDirector
- Mr. Bo LaiDirector
- Mr. Hongtao HeIndependent DirectorCN¥160,000
- Ms. Ling ShenIndependent DirectorCN¥160,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 58
- Environment
- 99
- Social
- 66
- Governance
- 9
- Direct emissions (scope 1)
- 47,548 t
- Energy emissions (scope 2)
- 65,418 t
- Women in the workforce
- 53.4876%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Chongqing Taiji Industry Group employs 12,704 full-time employees in the pharmaceutical sector.
- The company produces a wide range of products including capsules, syrups, and injections.
- Chongqing Taiji focuses on Chinese patent medicines and health care products for domestic and overseas markets.
Weaknesses
- Chongqing Taiji's business is primarily limited to the domestic market in China.
- The company's product range includes only traditional Chinese medicine formats.
- Chongqing Taiji does not have a significant presence in international markets beyond China.
Opportunities
- Chongqing Taiji can expand its overseas market presence for Chinese patent medicines.
- The growing demand for health care products in China offers opportunities for growth.
- The cultivation of medicinal herbs supports sustainable production of pharmaceuticals.
Threats
- Chongqing Taiji faces competition from other Chinese pharmaceutical companies.
- The pharmaceutical industry in China is highly regulated and competitive.
- Chongqing Taiji must comply with strict health care regulations in all markets.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.